ganesh raghu, MD, facp, fccp

Ganesh Raghu, MD, FACP, FCCP

Adjunct Professor, Laboratory Medicine
Division of Pulmonary and Critical Care Medicine
Director, Interstitial Lung Disease/Sarcoid/Pulmonary Fibrosis Program

Contact Information

University of Washington Medical Center
1959 N.E. Pacific, Campus Box 356175
Seattle, WA 98195-6522

graghu@u.washington.edu
Academic Office: (206) 598-6190
Fax: (206) 598-5305
Clinic Appointments: (206) 598-4615
Clinic Fax: (206) 598-2105

Return to Faculty Directory

Education and Training

M.D., Mysore Medical College, University of Mysore, Mysore, India, 1973.

Internship, University Hospitals, University of Mysore, Mysore, India, 1974.

Residency in General Medicine and Chest Medicine, Hartlepool General Hospital and Postgraduate Medical Center (University of Newcastle Upon Tyne), Hartlepool, England, 1977.

Residency in Internal Medicine, State University of New York, Buffalo, NY, 1980.

Chief Medical Resident, State University of New York, Buffalo, NY, 1980-1981.

Fellowship in Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, 1983.

Fellowship in Lung Cell Biology, University of Washington, Seattle, WA, 1985.

ACLS certified

Research Interests

Clinical:
       Diagnosis and treatment of interstitial lung diseases (ILD)
       Significance of gastroesophagial reflux in the management of ILD and IPF
       Role of HRCT and lung biopsy in idiopathic pulmonary fibrosis (IPF)
       Role of HRCT and lung biopsy in idiopathic pulmonary fibrosis (IPF)
       Genetic predisposition of idiopathic pulmonary fibrosis and familial IPF
       Management of sarcoidosis
       Outcome measures in IPF
       Lung transplantation: Treatment of rejection, infection

Basic Science: Pathogenesis of pulmonary fibrosis:
        Human lung fibroblast heterogeneity
        Genetic susceptibility of pulmonary fibrosis

Representative Publications

Raghu G, Brown K, Bradford W, Starko K, Noble P, Schwartz D, King T.  A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.  NEJM. 350:125-133, 2004

Azuma A, Nukiwa T, Tsuboi E, Suga M, Abe S, Nakata K, Taguchi Y, Nagai S, Itoh H, Ohi M, Sato A, Judoh S, Raghu G. Double blind, placebo-controlled trial of perfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005;171(9):1040-47.

Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, Sillery JK, Pope CE 2nd, Pellegrini CA. High prevalence of abnormal acid gastroesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006. Jan;27(1):136-42.

Raghu G, Weycker D, Bradford W, Oster G.  Incidenc

 

top of page